Biotech Values

[dewophile]

NLTX
The stock is down 15-20% of late - I assume this is the market souring on the cytokine space given the recent NKTR data in lung CA? Today it was disclosed that the general counsel is leaving maybe that leaked earlier?
I am still not a buyer of anything more than a token amount until we see some clinical data (and since it seems to trade in lock step w bempeg may be wise to wait for the melanoma data next year)